Perimyocarditis after COVID-19 mRNA Vaccine: The Role of Cardiac
Magnetic Resonance Imaging
- Ashwin Kumar,
- Evan Harmon,
- Abdullah Yesilyaprak,
- Ankit Agrawal,
- Sayan Manna,
- Paul Schoenhagen,
- Allan Klein
Abstract
A 22-year-old male presented with chest pain 3 days after his second
dose of the COVID-19 vaccine. Cardiac magnetic resonance imaging
demonstrated myocardial and pericardial enhancement. Given imaging and
clinical findings, he was diagnosed with perimyocarditis. He was treated
with a multitude of medications including NSAIDs, colchicine, and
steroids. Fortunately, he was able to achieve symptom improvement. Due
to COVID-19 vaccination novelty, further research is needed to identify
side effects.